• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Roche's $4.8B deal for Spark cleared by FTC after long delay

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 16, 2019 at 11:22: PM
via The Federal Trade Commission on Monday cleared Roche's $4.8 billion buyout of Spark Therapeutics, bringing to a close a 10-month investigation that had spurred concerns acquisitions of other gene therapy biotechs would be similarly scrutinized.

article source
 




Top Bottom
Back
Quote